Overnight Feeding Study in Glycogen Storage Disease Type 1
NCT01961076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2015-03-23
Summary
In this clinical cross-over study, we will compare the efficacy of different oral nutrition regimens for night-time glucose control in adult GSD 1 patients. Three different over-night nutrition regimens (=interventions) will be compared in each patient sequentially, (1) uncooked corn starch (UCSS, "Maizena"), (2) modified corn-starch, (3) other carbohydrate (starch) containing meal. During each intervention, glucose profiles will be continuously monitored by continuous glucose monitoring (CGMS). The duration of each intervention is 3d (mimimum) to 6d (maximum), depending on the quality of night-time glucose control and the technical quality of glucose sensor readings. Between the interventions, the patients follow their normal prescribed diet.
Conditions
- Glycogen Storage Disease Type 1 (GSD 1)
Interventions
- OTHER
-
overnight nutrition regime
Patients receive the specified overnight nutrition regimen
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Giatgen Spinas, Prof MD · University Hospital Zurich, Division of Endocrinology, Diabetes and Clinical Nutrition
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Metabolic Complications of Glucocorticoid Excess
NCT01319994 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice
NCT07252765 ·Status: RECRUITING
-
Insulinotropic Effect of GLP-1 and GIP After Dexamethasone
NCT02235584 ·Status: COMPLETED ·Phase: NA
-
Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes
NCT04416204 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
NCT02262832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
NCT04472962 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver
NCT01986231 ·Status: COMPLETED ·Phase: NA
-
A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis
NCT02157155 ·Status: COMPLETED ·Phase: NA
-
Triheptanoin in Mc Ardle
NCT02919631 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Oral vs Intravenous Glucose Administration on Novel Candidates of Energy Regulation
NCT04888325 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Receptor Expression in CHI
NCT03768518 ·Status: UNKNOWN
-
Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus
NCT05985135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Role of the Liver in Glucose Homeostasis Using Metabolic Imaging
NCT04352738 ·Status: COMPLETED
-
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
NCT00822003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Short Course of Glucocorticoid in Patients With Diabetes Mellitus(DM) Type 2
NCT03661684 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
Interplay Between Interleukin-6 and Glucagon in the Regulation of Human Amino Acid and Protein Homeostasis
NCT06721910 ·Status: COMPLETED ·Phase: NA
-
Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders
NCT07021456 ·Status: RECRUITING
-
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
NCT00784745 ·Status: COMPLETED ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
NCT00732602 ·Status: COMPLETED ·Phase: NA
-
β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed
NCT02199470 ·Status: COMPLETED
-
Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14
NCT03404856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2